Patterns of Drug Utilization in a Neonatal Intensive Care Unit
dc.contributor.author | Warrier, Indulekha | en_US |
dc.contributor.author | Du, Wei | en_US |
dc.contributor.author | Natarajan, Girija | en_US |
dc.contributor.author | Salari, Vali | en_US |
dc.contributor.author | Aranda, Jacob | en_US |
dc.date.accessioned | 2013-04-08T20:49:36Z | |
dc.date.available | 2013-04-08T20:49:36Z | |
dc.date.issued | 2006-04 | en_US |
dc.identifier.citation | Warrier, Indulekha; Du, Wei; Natarajan, Girija; Salari, Vali; Aranda, Jacob (2006). "Patterns of Drug Utilization in a Neonatal Intensive Care Unit." The Journal of Clinical Pharmacology 46(4). <http://hdl.handle.net/2027.42/97176> | en_US |
dc.identifier.issn | 0091-2700 | en_US |
dc.identifier.issn | 1552-4604 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/97176 | |
dc.publisher | Wiley Periodicals, Inc. | en_US |
dc.publisher | Blackwell Publishing Ltd | en_US |
dc.subject.other | Neonate | en_US |
dc.subject.other | Neonatal Intensive Care Unit | en_US |
dc.subject.other | Drug Utilization | en_US |
dc.title | Patterns of Drug Utilization in a Neonatal Intensive Care Unit | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Pharmacy and Pharmacology | en_US |
dc.subject.hlbsecondlevel | Pediatrics | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationother | Division of Neonatology, Children's Hospital of Michigan, Wayne State University, Detroit, Michigan. | en_US |
dc.contributor.affiliationother | Division of Pediatric Clinical Pharmacology, Children's Hospital of Michigan, Wayne State University, Detroit, Michigan. | en_US |
dc.identifier.pmid | 16554453 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/97176/1/0091270005285456.pdf | |
dc.identifier.doi | 10.1177/0091270005285456 | en_US |
dc.identifier.source | The Journal of Clinical Pharmacology | en_US |
dc.identifier.citedreference | Alexander GR, Kogan M, Bader D, Carlo W, Allen M, Mor J. US birth weight/gestational age‐specific neonatal mortality: 1995–1997 rates for whites, Hispanics, and blacks. Pediatrics. 2003; 111: e61 – 6. | en_US |
dc.identifier.citedreference | Early neonatal drug utilization in preterm newborns in neonatal intensive care units. Italian Collaborative Group on Preterm Delivery. Dev Pharmacol Ther. 1988; 11: 1 – 7. | en_US |
dc.identifier.citedreference | Blumer JL, Reed MD. Principles of neonatal pharmacology. In: Yaffe SJ, Aranda JV, eds. Neonatal and Pediatric Pharmacology. 3rd ed. Baltimore: Lippincott, Williams & Wilkins; 2005: 146 – 158. | en_US |
dc.identifier.citedreference | van den Anker, JN. Managing drugs safely. Semin Fetal Neonatal Med. 2005; 10: 73 – 81. | en_US |
dc.identifier.citedreference | Knight M. Adverse drug reactions in neonates. J Clin Pharmacol. 1994; 34: 128 – 135. | en_US |
dc.identifier.citedreference | Aranda JV. Factors associated with adverse drug reactions in the newborn. Pediatr Pharmacol 1983; 3: 245 – 249. | en_US |
dc.identifier.citedreference | Aranda JV, Clarkson S, Collinge JM. Changing pattern of drug utilization in a neonatal intensive care unit. Am J Perinatol. 1983; 1: 28 – 30. | en_US |
dc.identifier.citedreference | Daniell AJ, Darlow BA. Audit of drug usage in a regional neonatal intensive care unit. Aust Paediatr J. 1989; 25: 207 – 210. | en_US |
dc.identifier.citedreference | Kaufman D, Fairchild KD. Clinical microbiology of bacterial and fungal sepsis in very‐low‐birth‐weight infants. Clin Microbiol Rev. 2004; 17: 638 – 680. | en_US |
dc.identifier.citedreference | Roilides E, Farmaki E, Evdoridou J, et al. Neonatal candidiasis: analysis of epidemiology, drug susceptibility, and molecular typing of causative isolates. Eur J Clin Microbiol Infect Dis. 2004; 23: 745 – 750. | en_US |
dc.identifier.citedreference | Kossoff EH, Buescher ES, Karlowicz MG. Candidemia in a neonatal intensive care unit: trends during fifteen years and clinical features of 111 cases. Pediatr Infect Dis J. 1998; 17: 504 – 508. | en_US |
dc.identifier.citedreference | Stratov I, Gottlieb T, Bradbury R, O'Kane GM. Candidaemia in an Australian teaching hospital: relationship to central line and TPN use. J Infect. 1998; 36: 203 – 207. | en_US |
dc.identifier.citedreference | Johnsson H, Ewald U. The rate of candidaemia in preterm infants born at a gestational age of 23–28 weeks is inversely correlated to gestational age. Acta Paediatr. 2004; 93: 954 – 958. | en_US |
dc.identifier.citedreference | Glover DD, Amonkar M, Rybeck BF, Tracy TS. Prescription, over‐the‐counter, and herbal medicine use in a rural, obstetric population. Am J Obstet Gynecol. 2003; 188: 1039 – 1045. | en_US |
dc.identifier.citedreference | Henry A, Crowther C. Patterns of medication use during and prior to pregnancy: the MAP study. Aust N Z J Obstet Gynaecol. 2000; 40: 165 – 172. | en_US |
dc.identifier.citedreference | Stevenson DK, Verter J, Fanaroff AA, et al. Sex differences in outcomes of very low birthweight infants: the newborn male disadvantage. Arch Dis Child Fetal Neonatal Ed. 2000; 83: F182 – F185. | en_US |
dc.identifier.citedreference | Spitzer AR, Kirkby S, Kornhauser M. Practice variation in suspected neonatal sepsis: a costly problem in neonatal intensive care. J Perinatol. 2005; 25: 265 – 269. | en_US |
dc.identifier.citedreference | Toledano H, Schlesinger Y, Raveh D, et al. Prospective surveillance of vancomycin‐resistant enterococci in a neonatal intensive care unit. Eur J Clin Microbiol Infect Dis. 2000; 19: 282 – 287. | en_US |
dc.identifier.citedreference | Karlowicz MG, Buescher ES, Surka AE. Fulminant late‐onset sepsis in a neonatal intensive care unit, 1988–1997, and the impact of avoiding empiric vancomycin therapy. Pediatrics. 2000; 106: 1387 – 1390. | en_US |
dc.identifier.citedreference | Dasgupta SJ, Gill AB. Hypotension in the very low birthweight infant: the old, the new, and the uncertain. Arch Dis Child Fetal Neonatal Ed. 2003; 88: F450 – F454. | en_US |
dc.identifier.citedreference | Brion LP, Primhak RA, Ambrosio‐Perez I. Diuretics acting on the distal renal tubule for preterm infants with (or developing) chronic lung disease. Cochrane Database Syst Rev. 2002; 1: CD001817. | en_US |
dc.identifier.citedreference | Kaushal R, Bates DW, Landrigan C, et al. Medication errors and adverse drug events in pediatric inpatients. JAMA 2001; 285: 2114 – 2120. | en_US |
dc.identifier.citedreference | Gonzalez‐Martin G, Caroca CM, Paris E. Adverse drug reactions (ADRs) in hospitalized pediatric patients: a prospective study. Int J Clin Pharmacol Ther. 1998; 36: 530 – 533. | en_US |
dc.identifier.citedreference | Martinez‐Mir I, Garcia‐Lopez M, Palop V, Ferrer JM, Rubio E, Olivas FJ Morales A prospective study of adverse drug reactions in hospitalized children. Br J Clin Pharmacol. 1999; 47: 681 – 688. | en_US |
dc.identifier.citedreference | Roberts R, Rodriguez W, Murphy D, Crescenzi T. Pediatric drug labeling: improving the safety and efficacy of pediatric therapies. JAMA. 2003; 290: 905 – 911. | en_US |
dc.identifier.citedreference | Hines RN, McCarver DG. The ontogeny of human drug‐metabolizing enzymes: phase I oxidative enzymes. J Pharmacol Exp Ther. 2002; 300: 355 – 360. | en_US |
dc.identifier.citedreference | McCarver DG, Hines RN. The ontogeny of human drug‐metabolizing enzymes: phase II conjugation enzymes and regulatory mechanisms. J Pharmacol Exp Ther. 2002; 300: 361 – 366. | en_US |
dc.identifier.citedreference | Ten Eick AP, Reed MD. Clinical pharmacology research in the pediatric patient: the challenge continues. Prog Pediatr Cardiol. 2000; 12: 29 – 35. | en_US |
dc.identifier.citedreference | Choonara I. Unlicensed and off‐label drug use in children: implications for safety. Expert Opin Drug Saf. 2004; 3: 81 – 83. | en_US |
dc.identifier.citedreference | Assael BM. Therapeutic orphans: European perspective. Pediatrics. 1999; 104 (Pt 2): 591 – 592. | en_US |
dc.identifier.citedreference | Survey of the current state of pediatric drug use in Japan (1994–6). Drug Therapy Committee of the Japan Pediatric Society. Pediatr Int. 2000; 42: 109 – 113. | en_US |
dc.identifier.citedreference | Bonati M. Epidemiologic evaluation of drug use in children. J Clin Pharmacol. 1994; 34: 300 – 305. | en_US |
dc.identifier.citedreference | Gortner L. Drug utilisation in preterm and term neonates. Pharmacoeconomics. 1993; 4: 437 – 445. | en_US |
dc.identifier.citedreference | Lesko SM, Epstein MF, Mitchell AA. Recent patterns of drug use in newborn intensive care. J Pediatr. 1990; 116: 985 – 990. | en_US |
dc.identifier.citedreference | Aranda JV, Cohen S, Neims AH. Drug utilization in a newborn intensive care unit. J Pediatr. 1976; 89: 315 – 317. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.